FDA Approves New Hemophilia B Treatment

April 30, 2015

  Note: This is an edited version of a Emergent BioSolutions Inc.聽press release. To read the full release,聽click here. Emergent BioSolutions Inc. announced on Thursday, April 29 the聽U.S. Food and Drug Administration聽(FDA) has approved IXINITY庐, an intravenous recombinant human coagulation factor IX therapeutic for the control and prevention of bleeding episodes and for perioperative management […]

Sign up for E-mails, Dateline Magazine, and other ways to stay connected.